Diffusion Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
24.75
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-2.06
|
-1.37
|
0.69
|
33.50%
|
|
2022-06-30
|
-2.04
|
-2.06
|
-0.02
|
-0.98%
|
|
2022-03-31
|
-1.75
|
-2.22
|
-0.47
|
-26.86%
|
|
2021-12-31
|
-2.00
|
-2.00
|
0.00
|
0.00%
|
|
2021-09-30
|
-2.00
|
-1.50
|
0.50
|
25.00%
|
|
2021-06-30
|
-2.25
|
-2.00
|
0.25
|
11.11%
|
|
2021-03-31
|
-2.25
|
-3.00
|
-0.75
|
-33.33%
|
|
2020-12-31
|
-2.50
|
-3.00
|
-0.50
|
-20.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.65
|
|
2021-12-31
|
-8.50
|
|
2020-12-31
|
-13.00
|
|
2019-12-31
|
-2.15
|
|
2018-12-31
|
-5.96
|
|
2017-12-31
|
-3.76
|
|
2016-12-31
|
-26.89
|
|
2015-12-31
|
-136.06
|
|
2014-12-31
|
-3865.80
|
|
2013-12-31
|
-19635.44
|
|
2012-12-31
|
-62148.31
|
|
2011-12-31
|
-137589.92
|
|
2010-12-31
|
-31491.61
|
|
2009-12-31
|
-43697.31
|
|
2008-12-31
|
-4412910.23
|
|
1998-12-31
|
0.00
|